Breaking News, Collaborations & Alliances

Astellas & Yaskawa Partner to Develop a Robotic Cell Therapy Platform

Establish a joint venture for the development of a cell therapy product manufacturing platform utilizing the dual-arm robot ‘Maholo.’

Author Image

By: Charlie Sternberg

Associate Editor

Astellas Pharma Inc. and Yaskawa Electric Corporation have agreed to establish a joint venture for the development of a cell therapy product manufacturing platform utilizing the dual-arm robot “Maholo.” In addition, the joint venture aims to offer platform access to startups and academic institutions, fostering collaboration and innovation in the field of cell therapy. The joint venture will leverage Astellas’ expertise in R&D and manufacturing for cell therapy and the d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters